この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1997/9/301 分で読めます
Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients; Public Meeting
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing a public meeting to discuss issues related to the agency's proposed rule on regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients. The proposed rule, previously announced in the Federal Register, requested written comments and proposed new regulations requiring pediatric studies of certain new drug and biological products. The purpose of the meeting is to provide experts in the field and interested individuals an opportunity to discuss specific issues raised by the proposed rule. The agency is seeking comment and specific data on the proposed rule.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →